Back to search
FDAFDA · Food and drugs·Recall number D-0387-2022

Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50

Published January 26, 2022 · Recall initiated: January 14, 2022

Summary

FDA records drug Class II recall D-0387-2022, published January 26, 2022 and initiated January 14, 2022. Recalling firm: Mayne Pharma Inc; Status: Ongoing; Reported quantity: 17,113 canisters; Lot: Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mayne Pharma Inc
Distributor
Nationwide within the United States
Lot
Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50 recalled?

Yes. FDA published recall D-0387-2022 on January 26, 2022. Reported hazard: CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

What should I do if I have this product?

Voluntary: Firm initiated · Letter